Pharmacokinetics of the Carmustine Implant
暂无分享,去创建一个
[1] C. Patlak,et al. The Movements of Water and Solutes in the Brains of Mammals , 1976 .
[2] J. Tamada,et al. The development of polyanhydrides for drug delivery applications. , 1992, Journal of biomaterials science. Polymer edition.
[3] S. Piantadosi,et al. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors , 1997, Cancer Chemotherapy and Pharmacology.
[4] R Langer,et al. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. , 1985, Journal of Biomedical Materials Research.
[5] H. Brem,et al. New delivery systems for brain tumor therapy. , 1995, Neurologic clinics.
[6] J. Benoit,et al. Drug delivery into the brain using implantable polymeric systems , 1997 .
[7] R. Tamargo,et al. Brain biocompatibility of a biodegradable, controlled-release polymer in rats. , 1989, Journal of biomedical materials research.
[8] H. Brem,et al. Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNU , 1996 .
[9] R. Langer,et al. Interstitial Drug Therapy for Brain Tumors: A Case Study , 1990 .
[10] M. Westphal,et al. Glioma invasion in the central nervous system. , 1996, Neurosurgery.
[11] Rakesh K. Jain,et al. Vascular and interstitial barriers to delivery of therapeutic agents in tumors , 1990, Cancer and Metastasis Reviews.
[12] W. Mark Saltzman,et al. Distribution of nerve growth factor following direct delivery to brain interstitium , 1995, Brain Research.
[13] R Langer,et al. Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. , 1986, Journal of biomedical materials research.
[14] J Fenstermacher,et al. Drug “Diffusion” within the Brain a , 1988, Annals of the New York Academy of Sciences.
[15] S. Rapoport. Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications , 2000, Cellular and Molecular Neurobiology.
[16] H. Brem,et al. Biodegradable polymer implants to treat brain tumors. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[17] J. Villemure,et al. Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain. , 1994, Biomaterials.
[18] C. Nicholson. Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum. , 1995, Biophysical journal.
[19] G. Debrun,et al. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma. , 1985, Journal of neurosurgery.
[20] M. Zucchetti,et al. Do anticancer agents reach the tumor target in the human brain? , 2004, Cancer Chemotherapy and Pharmacology.
[21] R. Tamargo,et al. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. , 1993, Cancer research.
[22] Susan M. Chang,et al. Intratumoral chemotherapy. Commentaries , 1995 .
[23] Robert Langer,et al. Polyanhydrides. I: Preparation of high molecular weight polyanhydrides , 1987 .
[24] D. Rall,et al. The Antitumor Agent, 1,3-bis(2-chloroethyl)-1-nitrosourea , 1966 .
[25] Robert Langer,et al. INVITED REVIEW POLYMERIC DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE , 1980 .
[26] R. Langer,et al. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. , 2000, Accounts of chemical research.
[27] W. Mark Saltzman,et al. Transport and elimination of recombinant human NGF during long-term delivery to the brain , 1996, Brain Research.
[28] W. Saltzman,et al. Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants. , 1995, The Journal of pharmacology and experimental therapeutics.
[29] R. Whaley,et al. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas , 2004, Journal of Neuro-Oncology.
[30] Blasberg Rg,et al. Transport of material between brain extracellular fluid, brain cells and blood. , 1974 .
[31] W. Mark Saltzman,et al. Drugs released from polymers: diffusion and elimination in brain tissue , 1991 .
[32] S. A. Azizi,et al. Principles of treatment of malignant gliomas in adults: an overview. , 1998, Journal of neurovirology.
[33] R. Tamargo,et al. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. , 1992, Journal of neurosurgery.
[34] H Kalimo,et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. , 1997, Neurosurgery.
[35] R. Tamargo,et al. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. , 1989, Selective cancer therapeutics.
[36] V D Calhoun,et al. A finite element model for predicting the distribution of drugs delivered intracranially to the brain. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.
[37] H. Brem,et al. Polymers to treat brain tumours. , 1990, Biomaterials.
[38] Kochi,et al. High-dose chemotherapy with autologous hematopoietic stem-cell rescue for patients with malignant brain tumors. , 1999, Critical reviews in neurosurgery : CR.
[39] B. Teicher,et al. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo. , 1989, Cancer research.
[40] A. Olivi,et al. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. , 1994, Journal of neurosurgery.
[41] J. Li,et al. The delivery of BCNU to brain tumors. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[42] S. Piantadosi,et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas , 1995, The Lancet.
[43] H. Engelhard,et al. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma. , 2000, Surgical neurology.
[44] W. Saltzman,et al. Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders. , 1996, Journal of pharmaceutical sciences.
[45] D. Kondziolka,et al. Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. , 1999, Neurosurgery.
[46] P. Jenkins,et al. Hip complications following chemoradiotherapy. , 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).
[47] W. Mark Saltzman,et al. Chemotherapeutic Drugs Released from Polymers: Distribution of 1,3-bis(2-chloroethyl)-l-nitrosourea in the Rat Brain , 1996, Pharmaceutical Research.
[48] W. Saltzman,et al. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. , 1998, Cancer research.
[49] H. Reulen,et al. Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. , 1977, Journal of neurosurgery.
[50] H. Brem,et al. Morphological Characterization of Polyanhydride Biodegradable Implant Gliadel® During in Vitro and in Vivo Erosion Using Scanning Electron Microscopy , 1996, Pharmaceutical Research.
[51] R K Jain,et al. Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.
[52] A. Friedman,et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. , 1991, Journal of neurosurgery.
[53] P F Morrison,et al. Transport of cisplatin in rat brain following microinfusion: an analysis. , 1986, Journal of pharmaceutical sciences.
[54] A. Domb,et al. Preparation and Characterization of Carmustine Loaded Polyanhydride Wafers for Treating Brain Tumors , 1999, Pharmaceutical Research.
[55] M. Zucchetti,et al. Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin , 1999, Cancer Chemotherapy and Pharmacology.
[56] Henry Brem,et al. Polymers as controlled drug delivery devices for the treatment of malignant brain tumors , 1993 .
[57] W. Feindel,et al. Dynamics of Brain Edema , 1976, Springer Berlin Heidelberg.
[58] Richard Madsen,et al. Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review , 2004, Journal of Neuro-Oncology.
[59] J. Villemure,et al. Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain. , 1995, Biomaterials.
[60] J. Tamada,et al. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. , 1994, Journal of biomedical materials research.